Taltz and Zepbound used together provided comprehensive improvements in disease activity and patient-reported outcomes compared to Taltz monotherapy in TOGETHER-PsA study
HTGC Investors Have Opportunity to Lead Hercules Capital, Inc. Securities Fraud Lawsuit
NEW YORK, March 28, 2026 /PRNewswire/ —